Skip to main navigation Skip to search Skip to main content

Glucosinolates From Cruciferous Vegetables and Their Potential Role in Chronic Disease: Investigating the Preclinical and Clinical Evidence

  • Emma L. Connolly
  • , Marc Sim
  • , Nikolaj Travica
  • , Wolfgang Marx
  • , Gemma Beasy
  • , Gordon S. Lynch
  • , Catherine P. Bondonno
  • , Joshua R. Lewis
  • , Jonathan M. Hodgson
  • , Lauren C. Blekkenhorst*
  • *Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

An increasing body of evidence highlights the strong potential for a diet rich in fruit and vegetables to delay, and often prevent, the onset of chronic diseases, including cardiometabolic, neurological, and musculoskeletal conditions, and certain cancers. A possible protective component, glucosinolates, which are phytochemicals found almost exclusively in cruciferous vegetables, have been identified from preclinical and clinical studies. Current research suggests that glucosinolates (and isothiocyanates) act via several mechanisms, ultimately exhibiting anti-inflammatory, antioxidant, and chemo-protective effects. This review summarizes the current knowledge surrounding cruciferous vegetables and their glucosinolates in relation to the specified health conditions. Although there is evidence that consumption of a high glucosinolate diet is linked with reduced incidence of chronic diseases, future large-scale placebo-controlled human trials including standardized glucosinolate supplements are needed.

Original languageEnglish
Article number767975
JournalFrontiers in Pharmacology
Volume12
DOIs
Publication statusPublished - 26 Oct 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Glucosinolates From Cruciferous Vegetables and Their Potential Role in Chronic Disease: Investigating the Preclinical and Clinical Evidence'. Together they form a unique fingerprint.

Cite this